AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33479025 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm B (6MHP + IFA + mCy)
Number of subjects: 48
Study 33479025 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm C (6MHP + IFA + polyICLC)
Number of subjects: 48
Study 33479025 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm D (6MHP + IFA + polyICLC + mCy)
Number of subjects: 48
Study 32513684 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment effect heterogeneity across baseline risk
Number of subjects: 0
Study 32513684 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic models for RCT enrollment and treatment choice decisions
Number of subjects: 0
Study 32513684 — intervention group
Group type: COMPARATOR
Intervention: Distribution of risk within RCT
Number of subjects: 0
Study 32513684 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate of change of baseline risk over time
Number of subjects: 0
Study 35580835 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle-free local anaesthesia
Number of subjects: 8
Study 35580835 — intervention group
Group type: COMPARATOR
Intervention: Conventional local anaesthetic
Number of subjects: 8
Study 35580835 — intervention group
Group type: COMPARATOR
Intervention: Needle-free local anaesthesia and Conventional local anaesthetic
Number of subjects: 8
Study 33234644 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicines at Transitions Intervention (MaTI)
Number of subjects: 0
Study 33234644 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35403394 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster acupuncture at scalp points (Qianding to Baihui, Xinhui to Qianding), once a day, 5 days a week for 4 weeks
Number of subjects: 72
Study 35403394 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster acupuncture at scalp points
Number of subjects: 72
Study 35403394 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy
Number of subjects: 72
Study 32876010 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid 900 mg given twice weekly for 12 months
Number of subjects: 467
Study 32876010 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 467
Study 34657346 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming (interactive cycling at least twice a week for 6 months)
Number of subjects: 112
Study 34657346 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming
Number of subjects: 112
Study 34657346 — intervention group
Group type: COMPARATOR
Intervention: Control (regular activities)
Number of subjects: 112
Study 33641012 — intervention group
Group type: EXPERIMENTAL
Intervention: TLPLDC vaccine
Number of subjects: 144
Study 33641012 — intervention group
Group type: COMPARATOR
Intervention: Placebo (empty yeast cell wall particles and autologous dendritic cells)
Number of subjects: 144
Study 35841316 — intervention group
Group type: EXPERIMENTAL
Intervention: TS <7.8 cm training cohort
Number of subjects: 0
Study 35841316 — intervention group
Group type: EXPERIMENTAL
Intervention: TS ≥7.8 cm training cohort
Number of subjects: 0
Study 35841316 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms for TS <7.8 cm and TS ≥7.8 cm
Number of subjects: 0
Study 35841316 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation cohorts
Number of subjects: 0
Study 33409540 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment with steroids, six food elimination diet, mesalamine
Number of subjects: 50
Study 33409540 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis of autistic spectrum disorder (ASD)
Number of subjects: 50
Study 35679831 — intervention group
Group type: EXPERIMENTAL
Intervention: LAight® therapy (8 sessions during period B)
Number of subjects: 88
Study 35679831 — intervention group
Group type: EXPERIMENTAL
Intervention: LAight® therapy (group TC + L/L)
Number of subjects: 88
Study 35679831 — intervention group
Group type: EXPERIMENTAL
Intervention: LAight® therapy (group TC/L)
Number of subjects: 88
Study 35679831 — intervention group
Group type: COMPARATOR
Intervention: Topical clindamycin 1% solution (group TC)
Number of subjects: 88
Study 35679831 — intervention group
Group type: COMPARATOR
Intervention: Topical clindamycin 1% solution combined with LAight® therapy (group TC + L)
Number of subjects: 88
Study 35679831 — intervention group
Group type: EXPERIMENTAL
Intervention: LAight® therapy (during period B)
Number of subjects: 88
Study 33759656 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemicraniectomy (surgery)
Number of subjects: 151
Study 33759656 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 151
Study 34396868 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 60
Study 34396868 — intervention group
Group type: COMPARATOR
Intervention: Flank position
Number of subjects: 60
Study 32852967 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy with higher affiliative behaviors
Number of subjects: 90
Study 32852967 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy with nonreciprocal relationship in dominance dimension
Number of subjects: 90
Study 32852967 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy with complementarity in dominance dimension
Number of subjects: 90
Study 32852967 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy with interpersonal problems of communion
Number of subjects: 90
Study 36415151 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose administration
Number of subjects: 10
Study 36415151 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS administration
Number of subjects: 10
Study 36415151 — intervention group
Group type: COMPARATOR
Intervention: Comparison of glucose and LPS
Number of subjects: 10
Study 616505213 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative injection of botulinum toxin A (BTA) in the orbicularis muscle below the lower punctum of both eyes (group B)
Number of subjects: 60
Study 616505213 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative insertion of temporary extended duration silicone punctal plugs in the lower punctum of both eyes (group C)
Number of subjects: 60
Study 616505213 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical treatment with preservative‐free tear substitutes only (group A)
Number of subjects: 60
Study 616505213 — intervention group
Group type: EXPERIMENTAL
Intervention: Punctal plugs (group C)
Number of subjects: 60
Study 616505213 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA) (group B)
Number of subjects: 60
Study 34268372 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA)
Number of subjects: 24
Study 34268372 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline solution
Number of subjects: 24
Study 33028455 — intervention group
Group type: EXPERIMENTAL
Intervention: Lay idiom ('problems with your emotions or nerves')
Number of subjects: 0
Study 33028455 — intervention group
Group type: COMPARATOR
Intervention: Medical idiom ('problems with your mental health')
Number of subjects: 0
Study 33028455 — intervention group
Group type: COMPARATOR
Intervention: Medical idiom
Number of subjects: 0
Study 33028455 — intervention group
Group type: EXPERIMENTAL
Intervention: Lay idiom
Number of subjects: 0
Study 34217570 — intervention group
Group type: EXPERIMENTAL
Intervention: early-DTP vaccination
Number of subjects: 2398
Study 34217570 — intervention group
Group type: COMPARATOR
Intervention: no-DTP vaccination
Number of subjects: 2398
Study 34243101 — intervention group
Group type: EXPERIMENTAL
Intervention: GranaGard for 3 months
Number of subjects: 30
Study 34243101 — intervention group
Group type: EXPERIMENTAL
Intervention: GranaGard for 3 months, followed by placebo for 3 months
Number of subjects: 30
Study 34243101 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 30
Study 35856046 — intervention group
Group type: EXPERIMENTAL
Intervention: INSTR (therapeutic exercise program with instructions)
Number of subjects: 20
Study 35856046 — intervention group
Group type: COMPARATOR
Intervention: Control (therapeutic exercise program without instructions)
Number of subjects: 20
Study 32112550 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea syndrome (OSAS)
Number of subjects: 0
Study 32112550 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct observational case-control study
Number of subjects: 0
Study 32112550 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea syndrome (OSAS) in Asian population
Number of subjects: 0
Study 35972345 — intervention group
Group type: EXPERIMENTAL
Intervention: CIRAS model based on ascites discomfort score, plasma sodium levels, and diuretic treatment.
Number of subjects: 1162
Study 35972345 — intervention group
Group type: COMPARATOR
Intervention: Standard ascites classification (refractory vs. diuretic-responsive)
Number of subjects: 1162
Study 35972345 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-Pugh score, MELD, MELD-Na, MELD 3.0
Number of subjects: 1162
Study 36440779 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospekta, 1 tablet twice daily
Number of subjects: 363
Study 36440779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 363
Study 36440779 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospekta
Number of subjects: 363
Study 34071714 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFA-enriched hen eggs (1053 mg/day)
Number of subjects: 40
Study 34071714 — intervention group
Group type: COMPARATOR
Intervention: Regular hen eggs
Number of subjects: 40
Study 34071714 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFA-enriched hen eggs
Number of subjects: 40
Study 35967319 — intervention group
Group type: EXPERIMENTAL
Intervention: aGAPSS-IS nomogram
Number of subjects: 478
Study 35967319 — intervention group
Group type: COMPARATOR
Intervention: aGAPSS
Number of subjects: 478
Study 32191150 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfluorocarbon liquids
Number of subjects: 55
Study 32191150 — intervention group
Group type: COMPARATOR
Intervention: Control group (no perfluorocarbon liquids)
Number of subjects: 55
Study 32191150 — intervention group
Group type: EXPERIMENTAL
Intervention: A group (multiple layers)
Number of subjects: 55
Study 32191150 — intervention group
Group type: EXPERIMENTAL
Intervention: B group (single layer)
Number of subjects: 55
Study 34743118 — intervention group
Group type: EXPERIMENTAL
Intervention: VYC-20L (20 mg/mL hyaluronic acid gel with lidocaine) administered via cannula
Number of subjects: 60
Study 34743118 — intervention group
Group type: COMPARATOR
Intervention: Needle injection of VYC-20L
Number of subjects: 60
Study 34743118 — intervention group
Group type: EXPERIMENTAL
Intervention: VYC-20L via cannula
Number of subjects: 60
Study 34743118 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection-site responses (ISRs)
Number of subjects: 60
Study 34743118 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedural pain
Number of subjects: 60
Study 34743118 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events (AEs)
Number of subjects: 60
Study 36432601 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of IX-containing fruits (yellow cactus pear)
Number of subjects: 0
Study 36432601 — intervention group
Group type: COMPARATOR
Intervention: Placebo (white cactus pear)
Number of subjects: 0
Study 34864943 — intervention group
Group type: EXPERIMENTAL
Intervention: Maribavir 400mg BID
Number of subjects: 352
Study 34864943 — intervention group
Group type: COMPARATOR
Intervention: Investigator-assigned therapy (IAT)
Number of subjects: 352
Study 34864943 — intervention group
Group type: EXPERIMENTAL
Intervention: Maribavir
Number of subjects: 352
Study 36178200 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask anesthesia (LMA)
Number of subjects: 107
Study 36178200 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal intubation (ETT)
Number of subjects: 107
Study 34139320 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous ablation
Number of subjects: 272
Study 34139320 — intervention group
Group type: COMPARATOR
Intervention: Control (sorafenib or TARE)
Number of subjects: 272
Study 616026142 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL) therapy, 3 sessions over 45 days
Number of subjects: 28
Study 34652564 — intervention group
Group type: EXPERIMENTAL
Intervention: Viloxazine ER sprinkled on applesauce
Number of subjects: 25
Study 34652564 — intervention group
Group type: COMPARATOR
Intervention: Viloxazine ER intact capsule after a 10-h fast (control condition)
Number of subjects: 25
Study 34652564 — intervention group
Group type: EXPERIMENTAL
Intervention: Viloxazine ER intact capsule with a standard high-fat meal
Number of subjects: 25
Study 32172295 — intervention group
Group type: COMPARATOR
Intervention: Non-medicated ADHD children
Number of subjects: 63
Study 32172295 — intervention group
Group type: COMPARATOR
Intervention: Medicated ADHD children
Number of subjects: 63
Study 32172295 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual stimulus
Number of subjects: 63
Study 32172295 — intervention group
Group type: EXPERIMENTAL
Intervention: Variability of accommodation
Number of subjects: 63
Study 32172295 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-on-task
Number of subjects: 63
Study 32172295 — intervention group
Group type: EXPERIMENTAL
Intervention: Group differences in accommodation variability
Number of subjects: 63
Study 35727277 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-guided fibrosis ablation plus pulmonary vein isolation (PVI)
Number of subjects: 843
Study 35727277 — intervention group
Group type: COMPARATOR
Intervention: PVI alone
Number of subjects: 843
Study 35727277 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-guided fibrosis ablation plus PVI
Number of subjects: 843
Study 32985190 — intervention group
Group type: EXPERIMENTAL
Intervention: Guest removal
Number of subjects: 0
Study 32985190 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of external physical pressure
Number of subjects: 0
Study 32985190 — intervention group
Group type: EXPERIMENTAL
Intervention: Solvated species (1Cl·2H2O and 2Br·2H2O)
Number of subjects: 0
Study 32985190 — intervention group
Group type: COMPARATOR
Intervention: Chloro- and bromo-functionalized ligands
Number of subjects: 0
Study 35818280 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrofluoric Acid 9% + Silane + Orthodontic adhesive (Transbond™ XT Light Cure Adhesive Primer, 3M ESPE)
Number of subjects: 40
Study 35818280 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrofluoric Acid 9% + Universal adhesive (UA) (Scotchbond Universal®, 3M ESPE)
Number of subjects: 40
Study 35818280 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal adhesive (UA) only
Number of subjects: 40
Study 35818280 — intervention group
Group type: EXPERIMENTAL
Intervention: Monobond Etch & Prime® (Ivoclar) + UA
Number of subjects: 40
Study 33507809 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT + C (60 Gy of intensity-modulated radiation therapy over 6 weeks with concurrent weekly cisplatin)
Number of subjects: 306
Study 33507809 — intervention group
Group type: COMPARATOR
Intervention: IMRT (60 Gy intensity-modulated radiation therapy over 5 weeks)
Number of subjects: 306
Study 33507809 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT + C
Number of subjects: 306
Study 33507809 — intervention group
Group type: COMPARATOR
Intervention: IMRT
Number of subjects: 306
Study 32227643 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilaprisan 2 mg (single oral dose)
Number of subjects: 9
Study 32227643 — intervention group
Group type: COMPARATOR
Intervention: Control (normal renal function)
Number of subjects: 9
Study 34388288 — intervention group
Group type: EXPERIMENTAL
Intervention: ADAPT program
Number of subjects: 282
Study 34388288 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 282
Study 33511505 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiplayer, immersive, interactive virtual reality application (VR group)
Number of subjects: 289
Study 33511505 — intervention group
Group type: COMPARATOR
Intervention: Physical equipment (TP group)
Number of subjects: 289
Study 32942085 — intervention group
Group type: EXPERIMENTAL
Intervention: AMO-02 (tideglusib) 400 mg
Number of subjects: 16
Study 32942085 — intervention group
Group type: EXPERIMENTAL
Intervention: AMO-02 (tideglusib) 1000 mg
Number of subjects: 16
Study 32942085 — intervention group
Group type: EXPERIMENTAL
Intervention: AMO-02 (tideglusib)
Number of subjects: 16
Study 35061058 — intervention group
Group type: EXPERIMENTAL
Intervention: CEUS-guided PCNL
Number of subjects: 72
Study 35061058 — intervention group
Group type: COMPARATOR
Intervention: Conventional US-guided PCNL
Number of subjects: 72
Study 33470741 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA
Number of subjects: 12
Study 35904646 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples Employment Program (CEP), an eight-session program integrating job search strategies and couple communication sessions.
Number of subjects: 1477
Study 35904646 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples Employment Program (CEP)
Number of subjects: 1477
Study 32770616 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned Caesarean Section (CS)
Number of subjects: 434
Study 32770616 — intervention group
Group type: COMPARATOR
Intervention: Vaginal Delivery (VD)
Number of subjects: 434
Study 32012977 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) over the left primary motor cortex for five days, combined with patient-controlled intravenous morphine analgesia (PCA-IV).
Number of subjects: 55
Study 32012977 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS stimulation, combined with patient-controlled intravenous morphine analgesia (PCA-IV).
Number of subjects: 55
Study 35091049 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided 1 (USG1 - BCS 1-5/9)
Number of subjects: 72
Study 35091049 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided 2 (USG2 - BCS 6-9/9)
Number of subjects: 72
Study 35091049 — intervention group
Group type: COMPARATOR
Intervention: Palpation-guided 1 (PG1 - BCS 1-5/9)
Number of subjects: 72
Study 35091049 — intervention group
Group type: COMPARATOR
Intervention: Palpation-guided 2 (PG2 - BCS 6-9/9)
Number of subjects: 72
Study 34129958 — intervention group
Group type: EXPERIMENTAL
Intervention: Stochastic finite element model for bone-implant interface stiffness
Number of subjects: 0
Study 34129958 — intervention group
Group type: EXPERIMENTAL
Intervention: Gap closure and subsequent stiffening
Number of subjects: 0
Study 32336177 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) with curcumin 0.75 mg/mL and blue LED (67 mW/cm2, 20.1 J/cm2)
Number of subjects: 0
Study 32529929 — intervention group
Group type: EXPERIMENTAL
Intervention: Storytelling video about recovery following a suicide attempt
Number of subjects: 218
Study 32529929 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducational video about suicide
Number of subjects: 218
Study 35273944 — intervention group
Group type: EXPERIMENTAL
Intervention: Ada
Number of subjects: 600
Study 35273944 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheport
Number of subjects: 600
Study 35273944 — intervention group
Group type: COMPARATOR
Intervention: Online search engines
Number of subjects: 600
Study 32252783 — intervention group
Group type: EXPERIMENTAL
Intervention: Air Next spirometer
Number of subjects: 200
Study 32252783 — intervention group
Group type: COMPARATOR
Intervention: Conventional desktop spirometer
Number of subjects: 200
Study 32918272 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 8–10 mg/kg of body weight
Number of subjects: 94
Study 32918272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 32730930 — intervention group
Group type: EXPERIMENTAL
Intervention: ABGS (250 μg rhBMP6/mL ABC)
Number of subjects: 32
Study 32730930 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 32
Study 32730930 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 32
Study 36414208 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant-initiated, ad hoc navigation
Number of subjects: 0
Study 36414208 — intervention group
Group type: EXPERIMENTAL
Intervention: Study-directed proactive navigation
Number of subjects: 0
Study 36414208 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 34338413 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily
Number of subjects: 15
Study 34338413 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 36109206 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block
Number of subjects: 80
Study 36109206 — intervention group
Group type: COMPARATOR
Intervention: Video‐assisted paravertebral block (PVB)
Number of subjects: 80
Study 32567103 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-guided imagery rehearsal therapy
Number of subjects: 70
Study 32567103 — intervention group
Group type: COMPARATOR
Intervention: Wait-list condition
Number of subjects: 70
Study 32046793 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-GI trifle (sucrose; GI 65)
Number of subjects: 65
Study 32046793 — intervention group
Group type: COMPARATOR
Intervention: Lower-GI trifle (isomaltulose; GI 34)
Number of subjects: 65
Study 32171937 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard rehabilitation plus movement training (MOVE)
Number of subjects: 150
Study 32171937 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation without movement training (CONTROL)
Number of subjects: 150
Study 35090838 — intervention group
Group type: EXPERIMENTAL
Intervention: Inventory of Anal Sex Knowledge (iASK) measure
Number of subjects: 154
Study 35090838 — intervention group
Group type: COMPARATOR
Intervention: HIV Knowledge Questionnaire (HIV-KQ-18)
Number of subjects: 154
Study 35090838 — intervention group
Group type: COMPARATOR
Intervention: STD-Knowledge Questionnaire (STD-KQ)
Number of subjects: 154
Study 35090838 — intervention group
Group type: COMPARATOR
Intervention: Patient Health Questionnaire (PHQ-2)
Number of subjects: 154
Study 35090838 — intervention group
Group type: COMPARATOR
Intervention: Generalized Anxiety Disorder scale (GAD-2)
Number of subjects: 154
Study 35090838 — intervention group
Group type: COMPARATOR
Intervention: Employment status
Number of subjects: 154
Study 33964140 — intervention group
Group type: EXPERIMENTAL
Intervention: High plasma HDL cholesterol concentrations (extreme high levels)
Number of subjects: 111984